This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Lung Cancer
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
-
Scripps Memorial Hospital, Encinitas, California, United States, 92024
Centura Health, Lakewood, Colorado, United States, 80228
VA Connecticut Healthcare System, West Haven, Connecticut, United States, 06516
Orlando Health, Inc., Orlando, Florida, United States, 32806
Sarasota Memorial Hospital, Sarasota, Florida, United States, 34239
St. Elizabeth Edgewood Hospital, Edgewood, Kentucky, United States, 41017
Norton Cancer Institute, Louisville, Kentucky, United States, 40202
Owensboro Health, Owensboro, Kentucky, United States, 42303
Johns Hopkins Medical Center, Baltimore, Maryland, United States, 21287
Lahey Hospital and Medical Center, Burlington, Massachusetts, United States, 01805
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
50 Years to 80 Years
ALL
No
Nucleix Ltd.,
Radha Duttagupta, PhD, STUDY_DIRECTOR, Nucleix Ltd.
2025-09